Ann: MSB to Host Virtual Symposium with KOL on GvHD, page-7

  1. 6,158 Posts.
    lightbulb Created with Sketch. 1096
    The key take is that the Mesoblast has a high chance of becoming the standard of care in the US for GVHD in children and probably globally with label extension potential in adults.

    note: the company is most likely the standard of care in Japan now for GVHD

    plans are in place to hit the ground running and much work has been done to ensure the are ready for Launch pending approval.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.41
Change
0.620(34.6%)
Mkt cap ! $3.084B
Open High Low Value Volume
$1.90 $2.48 $1.90 $58.82M 25.68M

Buyers (Bids)

No. Vol. Price($)
3 100915 $2.40
 

Sellers (Offers)

Price($) Vol. No.
$2.41 99 1
View Market Depth
Last trade - 16.12pm 18/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.